Jiawei Biological-B (06998.HK) announced its interim results, with a gross profit of 32.245 million yuan, an increase of 128.35% year-on-year.

Financial news from the Wisdom Finance APP, Jiahe Biotechnology-B (06998.HK) released its interim performance for the six months ending June 30, 2025, with a revenue of 32.245 million yuan (RMB, the same below), an increase of 122.84% year-on-year; gross profit of 32.245 million yuan, an increase of 128.35% year-on-year.